PEN News and Press, Penumbra Inc. From 09/01/23

2023-09-01 16:00:00 ET Summary Shares of Penumbra, Inc. have sold off sharply, but have started to recover after a 4-week base. Q2 FY'23 results show sales growth and a return of operating leverage, with management raising guidance for the full year. The stock is pricey no dou...

2023-08-23 11:30:00 ET Summary Diamond Hill invests on behalf of clients through a shared commitment to its valuation-driven investment principles, long-term perspective, capacity discipline and client alignment. The portfolio trailed the Russell 1000 Index and the blended benchma...

(NewsDirect) Peninsula Energy Ltd (ASX:PEN, OTCQB:PENMF) CEO Wayne Heili tells Proactive the company is adopting an accelerated plan for in-house resin processing and dry yellowcake uranium production, aiming to become a fully independent end-to-end producer of the partially refined ore. ...

2023-08-01 23:10:02 ET Penumbra, Inc. (PEN) Q2 2023 Earnings Conference Call August 1, 2023, 04:30 PM ET Company Participants Jee Hamlyn-Harris - IR Adam Elsesser - Chairman and CEO Maggie Yuen - CFO Jason Mills - EVP, Strategy Conference Call Participa...

2023-08-01 16:19:06 ET Penumbra press release ( NYSE: PEN ): Q2 GAAP EPS of $0.48 beats by $0.20 . Revenue of $261.5M (+25.5% Y/Y) beats by $8.25M . Company is increasing its guidance for 2023 total revenue to be in the range of $1.05 billion to $1.07 billion. ...

Penumbra, Inc. Reports Second Quarter 2023 Financial Results PR Newswire ALAMEDA, Calif. , Aug. 1, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the second quarte...

Penumbra, Inc. to Present at the Canaccord Genuity 43rd Annual Growth Conference PR Newswire ALAMEDA, Calif. , July 26, 2023 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity 43rd ...

2023-07-19 19:34:58 ET Baird has initiated coverage of medtech Penumbra ( NYSE: PEN ) with an outperform rating, citing its high revenue growth potential. Calling Penumbra a "leading innovator" in the multi-billion dollar neuro/vascular mechanical thrombectomy market, the invest...

2023-07-12 06:00:00 ET Summary ClearBridge is a leading global asset manager committed to active management. Research-based stock selection guides our investment approach, with our strategies reflecting the highest-conviction ideas of our portfolio managers. The Strategy underperf...

2023-07-09 18:15:18 ET Acumen Pharmaceuticals ( NASDAQ: ABOS ), Establishment Labs ( NASDAQ: ESTA ), Arcus Biosciences ( NYSE: RCUS ) and BridgeBio Pharma ( NASDAQ: BBIO ) are four of BTIG's top picks for small and mid-cap healthcare stocks going into the lat...